English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/91931
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Cooperative effect of 5-aminolevulinic acid and gold nanoparticles for photodynamic therapy of cancer

AuthorsBenito, Marta; Martin, Virginia ; Blanco, M.D.; Teijón, J.M.,; Gómez, C.
Keywordsphotodynamic therapy
gold nanoparticle
Issue Date2013
PublisherJohn Wiley & Sons
CitationJournal of Pharmaceutical Sciences 102: 2760- 2769 (2013)
AbstractAn enhanced capacity for protoporphyrin IX (PpIX) synthesis through 5- aminolevulinic acid (ALA) administration has been reported in cancer cells. We compared the effect of ALA and ALA combined with gold nanoparticles (ALA–AuNPs) for photodynamic ther- apy (PDT) on human cervical cancer cell line. Because PpIX after photoactivation produces reactive oxygen species (ROS), ALA–AuNPs combinations can enhance this production and then induce higher phototoxicity. With this aim, two different-sized AuNPs (14 and 136 nm, AuNP1 and AuNP2, respectively) were successfully synthesized and characterized by UV–visi- ble spectrophotometry and transmission electron microscopy. AuNPs were combined with ALA to evaluate their cooperative action in the intracellular ROS production, cell viability, and cell death mechanism. Results showed that ALA–AuNPs combinations induced cell death via ROS- mediated apoptosis after PDT. When exposed to light at their resonance wavelength, AuNP2 combined with ALA result in cytotoxicity and cell injury in greater extension than ALA and ALA–AuNP1 combination
Identifiersdoi: 10.1002/jps.23621
issn: 0022-3549
Appears in Collections:(IQFR) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.